New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease

@article{Goetz2010NewDI,
  title={New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease},
  author={Christopher G Goetz},
  journal={Movement Disorders},
  year={2010},
  volume={25}
}
  • C. Goetz
  • Published 2010
  • Psychology, Medicine
  • Movement Disorders
Increasing research efforts are focused on nonmotor aspects of Parkinson's disease (PD). Depression, anxiety, compulsivity (dopamine dysregulation symptoms), and hallucinations/psychosis are among these disorders, and all complicate the management of PD with negative influences on quality of life. There is a strong overlap between depression and apathy and likewise, depression and anxiety can coexist and require careful pharmacologic management. Dopamine dysregulation syndrome is linked to… Expand
Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review.
TLDR
Results of individual studies varied significantly; however, the randomized controlled trials showed encouraging results and support the need for further investigation of the utility of CBT for depressed and anxious patients with PD. Expand
Imaging correlates of apathy and depression in Parkinson's disease
TLDR
Depression in PD has been specifically associated with morphological and functional changes in prefrontal cortex, cingulate and thalamus, as with 5-HT transmission reduction in posterior cingulated and amygdala-hippocampus complex. Expand
The psychosis spectrum in Parkinson disease
TLDR
This work discusses recent developments, including recognition of an increase in the prevalence of psychosis with disease duration, addition of new visual symptoms to the psychosis continuum, and identification of frontal executive, visual perceptual and memory dysfunction at different disease stages. Expand
Psychosis and Parkinson’s Disease
TLDR
Effective and well-studied treatments that improve Parkinson’s disease psychosis without worsening motor function are still needed. Expand
Anxiety in Parkinson’s disease: A critical review of experimental and clinical studies
TLDR
The data reviewed here indicate that, despite their high prevalence and impact on the quality of life, anxiety disorders are often under-diagnosed and under-treated in PD patients. Expand
Diagnostic Overshadowing of Anxiety in Parkinson Disease: Psychosocial Factors and a Cognitive-Behavioral Model
  • Emma Stephens, Leon Dysch, J. Gregory
  • Medicine, Psychology
  • Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology
  • 2018
TLDR
A prominent finding was that individuals with motor fluctuation appeared to be more vulnerable to anxiety, and a cognitive-behavioral model of anxiety in PD is proposed and illustrated with a clinical example. Expand
[Sleep disturbances in patients with Parkinson disease].
TLDR
The favorable responses to dopaminergic medications in treating both RLS and PD suggest shared pathophysiologies between the two diseases; however, neuroimaging studies of dopamine systems remain inconclusive. Expand
Management of anxiety and motor symptoms in Parkinson’s disease
TLDR
This review considers the cyclic interaction between anxiety and motor symptoms in PD, each exacerbating the other when they coexist. Expand
Motion and emotion: anxiety–axial connections in Parkinson’s disease
TLDR
Whether PD patients suffering from axial symptoms have higher levels of anxiety than others is determined and other factors associated with anxiety–axial connections are identified to provide complex management options of these serious symptoms. Expand
Anxiety and depression in patients with Parkinson's disease.
TLDR
Findings indicate that recognizing anxiety and depression in patients with PD is important, since both conditions are commonly observed in Patients with PD and are similarly associated with the QOL, independent of motor severity. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 83 REFERENCES
The presence of depression and anxiety in Parkinson's disease.
TLDR
The PCP can play a critical role in insuring that depression and anxiety are identified and appropriately treated to minimize their impact on reality-of-life and further amplification of the disabilities of PD. Expand
Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group
TLDR
The proposed diagnostic criteria are provisional and intended to be defined further and validated but provide a common starting point for clinical research in PD‐associated depression. Expand
Visual hallucinations associated with Parkinson disease.
TLDR
While reduction in levodopa and anticholinergic medication doses is appropriate in the management of hallucinations, the factors that predispose patients to hallucinations include dementia and advancing age. Expand
Psychiatric comorbidity in a population of Parkinson's disease patients
TLDR
The findings might suggest the existence of a wide spectrum of psychiatric disorders in PD ranging from pure depressive disorders, comorbid depressive and anxiety disorders, and pure anxiety Disorders, presumably linked to the same neurobiological substrate. Expand
Medication-related impulse control and repetitive behaviors in Parkinson's disease
TLDR
Clinicians should warn patients prior to initiating dopamine agonists and enquire about these behaviors during follow up, which can affect up to 14% of Parkinson's disease patients on dopamine agonist medications. Expand
Dissociating apathy and depression in Parkinson disease
TLDR
Patients with Parkinson disease (PD) experienced significantly higher frequency and severity of apathy when compared with patients with dystonia, suggesting apathy may be a “core” feature of PD and occurs in the absence of depression. Expand
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
  • B. Ravina, K. Marder, +15 authors C. Goetz
  • Psychology, Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • 2007
TLDR
It is suggested that PDPsy may result from progression of the disease process underlying PD, rather than a comorbid psychiatric disorder or drug intoxication, and are a potential indication for therapy development. Expand
Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.
TLDR
Findings indicate that, when minor hallucinations are included, the total prevalence of hallucinations in Parkinson's disease is much higher than previously reported, and a simple side-effect of dopaminergic treatment is not sufficient to explain the occurrence of all visual hallucinations. Expand
Major and minor depression in Parkinson's disease: a neuropsychological investigation
TLDR
The results indicate that major depression in PD is associated with a qualitatively specific neuropsychological profile that may be related to an alteration of prefrontal and limbic cortical areas, and suggests that in these patients MiD and MD may represent a gradual continuum associated with increasing cognitive deficits. Expand
Depression rating scales in Parkinson's disease: Critique and recommendations
  • A. Schrag, P. Barone, +9 authors C. Goetz
  • Psychology, Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • 2007
TLDR
A systematic literature review was conducted to explore the use of depression scales in PD and determine which scales should be selected, and found that the complex and time‐consuming task of developing a new scale to measure depression specifically for patients with PD is currently not warranted. Expand
...
1
2
3
4
5
...